Capricor Therapeutics Inc 뉴스 - CAPR | 주식 나스닥

개인 투자자를 위한 전문가급 도구.

프리미엄

Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program

U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy...

Form S-8 - Securities to be offered to employees in employee benefit plans

Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Biologics License Application (BLA) for deramiocel in the treatment of Duchenne muscular dystrophy (DMD...

Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...

Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13

SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...

Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

-Company remains on track for PDUFA target action date of August 31, 2025- -Advisory committee meeting to be...

Anyone want to explain this complete pump eradication? It lasted 8 months... so... congrats on that, bulls.

So far it has been profitable to sell cash covered puts on this one when it has big drops, so I guess I should be happy for the opportunity, but I must say I did not expect to be looking at the 5's again. Only six weeks ago, I was selling a 25 call.

👍️0

koolmc 1 월 전

on watch again for another trade over reaction should see 10's again

👍️0

koolmc 2 월 전

trying for 14's now :)

if it breaks 12 and hold then uptrend confirms, although market not helping would be up more, but someone got a heads up here :)

👍️0

koolmc 2 월 전

yep finally sold some today after averaging down, will hold some into the forward event gl.

Bought back at 12.80 from 14.40.

👍️0

koolmc 3 월 전

added 12 on dip, also got shares for short term trading gl

👍️0

koolmc 3 월 전

there it is below 12's again

👍️0

koolmc 3 월 전

up in down market today.

👍️0

koolmc 3 월 전

up in down market today.

👍️0

ed3/6me 3 월 전

Mid 12 is target again

👍️0

koolmc 3 월 전

Yep got plenty of time to accumulate cheapies before expected approval date wouldn't mind below 12s again to add.

👍️0

ed3/6me 3 월 전

waITING ON SIDELINES. AS THEY ARE NOT AGRESSIVE ENOUGH TO PUSH BUYING PRESSURE AS OF YET. THEY NEED SOMETHING TO STIMULATE THE NEED TO BE AGRESSIVE HERE.

👍️0

koolmc 3 월 전

yep same here will add to starter position i got last week for push into august then sell on news

👍️0

ed3/6me 3 월 전

Sold at 14.40 waiting now

👍️0

enthalpy 3 월 전

It was strictly options and a great ER. Did you listen to it? I am going to load the boat in late April or early May probably another 20k. Wishing you and your family well. Enthalpy.

👍️0

enthalpy 3 월 전

Hey Ed. Q4 2024 was a good time was is it not on CAPR. This is company is going to make it i think. ESpecially now that SRPT killed a kid. CAPR might become number 1 in DMD if they can get their drug approved. I sold a chunk at $18. Bought back at 11.80. Hope your doing man.

👍️0

ed3/6me 3 월 전

ANY RATIONAL TO THE BUMP YESTERDAY? THOUGHT THE TREND WAS SLIGHTLY LOWER TILL NEXT QUARTER AS THE COMPANY STILL HAS NO REAL APPROVAL YET

👍️0

ed3/6me 3 월 전

Agree about timing this. Lately it's a crapshoot anywhere. Market is unstable at best while war and tariffs/inflation are on front burner. Judges blocking the inevitable re evaluation of scope of government outreach clouds the pictures market cannot get a clear sense of direction. Think we still have 2-3 months of bounce here in investment land

👍️0

GreedyAgorist 3 월 전

So the bumpy ride is thanks to delaying the earnings report twice? (Or maybe the brokers were giving me bad info just to make me look foolish for the last two weeks.)

: - )

Now I wonder... does clearing this hurdle mean the monthly bottom was yesterday? Two days left for options expiration.
I will be picking up more shares at the end of the week. Just not sure how many. Price below or above 12.50 will determine that.

👍️0

ed3/6me 3 월 전

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the fourth quarter and full year ended December 31, 2024, after the market close on Wednesday, March 19, 2025. Management will then host a webcast and conference call at 4:30 p.m. ET on March 19.

Sorry, I could have sworn earnings were Wednesday last week, but they are this coming week, 3/12 after hours. Did one or two brokers lead me astray? Or was I looking at Rigetti or some other speculative play on my watchlist and got confused? Anyway…

Last week we did get some corporate stuff, some Form 4’s and an 8K, but no earnings yet. I thought the wild swings were in response to a quarterly report, and the worst of it was over, but no such luck.

Well, if it drops to 12, I will sell a 10 for April. Good luck to all.

And condolences to anyone who loses somebody over this stupid DST nonsense. When exactly does the making ourselves healthy again start? Certainly not this weekend.

👍️0

ed3/6me 3 월 전

can live with price short term. and hope they finally get going toward some kind of goal

👍 1

ed3/6me 3 월 전

Thanks. Will pay better attention next time

👍️0

GreedyAgorist 3 월 전

You realize that earnings is today after hours. No doubt they will post a loss, as we are not at the point of having positive revenue yet, but just need to not disappoint.

Well, at least if you bought today, that is better than the recent top when it was 30% more expensive.

Still two and a half weeks until March contracts expire. A risk taker would position today, not wait until tomorrow, after the report. How brave am I feeling?

👍️0

ed3/6me 3 월 전

Jumped back in. Hope it helps me

👍️0

GreedyAgorist 4 월 전

Wow, I hardly ever perfectly time the bottom, but I sold a cash covered put today when it was red, and before I could second guess my play, it was green and up more than two bucks.

Any explanation for the 12% gain?

Oh, well, we were here ten days ago. Nothing to get excited about, right?

👍️0

Mr.Mister 5 월 전

With BLA submission in late December, when would the FDA have to accept or reject their application by? Late February?

👍️0

Volcano 5 월 전

Breaking out now
Get ready for $70 upon FDA approval

💯 1 🔥 1

Volcano 5 월 전

Price target $70-$100 upon FDA approval in a few months
Multi millionaire soon to be

👍 1

XWAVXALMIMAN 5 월 전

We got the news. We finished the submission and got $10 million. People are so impatient. I’ve waited 4 1/2 years. I can wait 6-9 months for approval. Families and patients should be pushing for a much quicker approval. 30-40 in 2025.

My question to you CAPR folks who are likely more versed than I. Is after the submission is sent to FDA for approval (in your case Deramiocel (CAP-1002)) - How long does it take FDA to make a decision on average?

I am following another company MNMD that is in Phase 3 right now for LSD that got FDA Break Through Designation.

👍️0

GreedyAgorist 6 월 전

Guess I was wrong about the new 5. It is not 20 or 17.50. Not yet. Those were the pump prices. If the pump is over for now, we might hang out around 12.50 for a while, making puts at 12.50 and 10 interesting. Likewise calls at 15 might be worth a shot. Although my next play is targeting March 17.50. If it gets there early, that will inform my next move.

👍️0

XWAVXALMIMAN 6 월 전

You’ll be sorry. Definitely an easy double from here within a year. I’ve held most shares for 4 1/2 years. Be patient. Linda sounded great - listened to interview last night after 12 days in Puerto Vallarta

👍️ 1

Laster 6 월 전

Got out yesterday afternoon before that huge dump.
It looked like it wanted to drop below $16.
Crazy AH trading down to $11 and back to $16.
Concern about one of their investigators.
Either way, I am out and hope others can make a better trade than I did. Now moving my money to other more quality stocks. JMO.

👍️0

D-bol 6 월 전

What a day. Still not selling.

👍️0

PonkenPlonken 6 월 전

RFK is irrelevant to how CAPR moves.

Everything is in the price here... plus a lot of birds in the bush. Why anyone would hold this stock AFTER it all happened, no catalyst on the horizeon. Presentation roadmap ends at "today".... is clear indication they know nothing will happen for a good year or two. So it will need a breather - which I believe you see in the chart.

Bios run towards events - not because of them.
GL

👍️0

Laster 6 월 전

Thank you. I have patience and can wait for mid 2025.
The problem is the biotech sector. It has gotten destroyed since Trump picked RFK Jr. as HHS secretary. Hopefully it will recover if RFK Jr. somehow doesn’t get the job.
Just hate the BS manipulation to drop stocks on no news. The stock market is a joke. Many Stocks now move on no news. I have seen stocks move from $1 to $10 on nothing. How is that possible or legal?
Just hope it doesn’t drop lower than $15. Then I might have to throw in the towel and move on.

👍️0

PonkenPlonken 6 월 전

This stock trades on a lot of hopes, dreams and "ifs".
Not unlikely that whatever they announce, it will be a sell on news event.
It believe it has to cool off until the PDUFA which is ca 1 year away.
When the roadmap a company gives in their presentation ends with "today"...... is usually not a good sign. That is speaking in terms of PPS. For the company, everything is well and funding wont be an issue.

👍️0

Laster 6 월 전

Now down to $17.50. WOW. I can only guess people were expecting news on the BLA submission.
Maybe they are getting financing through the ATM and selling into the market.
Either way, this doesn't look good today.

👍️0

Laster 6 월 전

This stock is ridiculous. I don't know if it is manipulation or MMs getting the stop losses?
Opened at $19.44 and then in 1 minute it went to $20.75 and then the next minute it is down to $18.92.
Clearly, someone continues to keep this below $20. When will they be done????
This is criminal IMO. I am holding because I think it makes a run to $30 once all this crap is over.
MACD histogram on the daily is going to turn positive today.
JMO.

👍️0

Laster 6 월 전

The stock chart looks interesting. The MACD histogram is ready to turn positive.
The stock found support at the 25 day moving average.
PnF chart clearly shows double/triple top breakout past $21.
Nice flag forming. Needs volume to move past $20.
I think the stock will need BLA news to get the volume to move past $20.
I am looking for $30-$40 by mid 2025.

FYI. Conferences this week and next week.
Perfect time to release some updates.

👍 1

Laster 7 월 전

Well yesterday sucked. Moved BACK to $20 again only to get dumped back down to $19.
Looks like it will need significant volume to move back above $20.
2 conferences in early to mid December might help.
Happy Thanksgiving.

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Capricor Therapeutics Inc (CAPR)

개인 투자자를 위한 전문가급 도구.

CAPR 뉴스

Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program

Form S-8 - Securities to be offered to employees in employee benefit plans

Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13

Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

CAPR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Capricor Therapeutics Inc (CAPR) 뉴스

Capricor Therapeutics Inc (CAPR)

개인 투자자를 위한 전문가급 도구.

CAPR 뉴스

Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program

Form S-8 - Securities to be offered to employees in employee benefit plans

Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13

Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

CAPR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

로그인

광고 제거